Jose E Meca-Lallana Selected Research

Monoclonal Antibodies

1/2022

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose E Meca-Lallana Research Topics

Disease

2	Multiple Sclerosis 01/2022 - 04/2013
1	Demyelinating Diseases (Demyelinating Disease) 04/2013

Drug/Important Bio-Agent (IBA)

1	Monoclonal AntibodiesIBA 01/2022
1	ofatumumab FDA Link 01/2022
1	SteroidsIBA 04/2013

Therapy/Procedure

1	Plasma Exchange 04/2013
1	Therapeutics 04/2013